Dolski Robert 4
4 · Checkmate Pharmaceuticals, Inc. · Filed Jan 31, 2022
Insider Transaction Report
Form 4
Dolski Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-27+101,180→ 101,180 totalExercise: $2.05Exp: 2032-01-26→ Common Stock (101,180 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on January 27, 2023 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.